Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.005 USD | -.--% | -28.57% | +16.28% |
2023 | Amarin, Lotus Pharmaceuticals Agree to Exclusive Vazkepa Distribution Deal in 10 Asian Countries | MT |
2021 | Thai oil firm PTT expands pharma business with $475 million Alvogen deal | RE |
Quotes 5-day view
Delayed Quote OTC Markets2024-04-23 | 2024-04-25 | |
---|---|---|
Last | 0.005 $ | 0.005 $ |
Volume | 39 766 | 10 000 |
Change | +∞% | -.--% |
Opening | 0.01 | 0.01 |
High | 0.01 | 0.01 |
Low | 0.00 | 0.01 |
Performance
1 week | -28.57% | ||
3 months | +16.28% | ||
6 months | -24.24% | ||
Current year | +16.28% | ||
1 year | -54.55% | ||
3 years | -89.41% | ||
5 years | -43.18% | ||
10 years | -79.84% |
Volumes
marketsBasic data
Highs and lows
Indicators
Sector Comparison - Generic Pharmaceuticals
Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
---|---|---|---|---|---|---|
-.--% | -28.57% | +16.28% | -54.55% | 14.72M | ||
+1.32% | +2.45% | +20.76% | +56.31% | 43.18B | ||
-2.87% | +0.44% | +20.40% | +36.56% | 22.59B | ||
+1.60% | +0.42% | +15.11% | - | 14.56B | ||
+2.32% | +1.67% | +41.54% | +88.70% | 11.5B | ||
-1.10% | +0.46% | -8.55% | -16.42% | 6.93B | ||
-.--% | +0.14% | - | - | 6.79B | ||
-.--% | -1.95% | - | - | 5.73B | ||
+0.52% | +3.48% | +10.21% | +22.69% | 5.36B | ||
+0.31% | +10.83% | -2.27% | -11.16% | 4.81B | ||
+1.20% | +7.63% | +6.40% | +13.95% | 4.68B | ||
-.--% | +0.80% | +14.55% | +12.50% | 4.15B | ||
+2.12% | -2.36% | +30.33% | +158.72% | 3.78B | ||
+0.69% | +2.86% | +24.61% | +95.64% | 3.57B | ||
+0.84% | +4.77% | +7.12% | +72.60% | 3.34B | ||
-0.63% | +0.96% | -10.21% | -0.05% | 2.9B | ||
Average | +0.38% | +1.76% | +13.31% | +36.58% | ||
Weighted average by Cap. | +0.36% | +1.68% | +17.71% | +47.36% |
Historical data
Date | Opening | High | Low | End-of-day | Volume |
---|
Monthly variations
Annual change
2024 | +17.65% | ||
2023 | -57.50% | ||
2022 | -41.00% | ||
2021 | +54.09% | ||
2020 | -23.61% | ||
2019 | +260.00% | ||
2018 | +11.11% | ||
2017 | +63.64% | ||
2016 | -68.57% | ||
2015 | -2.78% | ||
2014 | -52.00% | ||
2013 | +36.36% | ||
2012 | -96.86% | ||
2011 | -86.49% | ||
2010 | +1.17% | ||
2009 | +539.68% | ||
2008 | -81.64% | ||
2007 | -56.40% | ||
2006 | -37.50% |
- Stock Market
- Equities
- LTUS Stock
- Quotes Lotus Pharmaceuticals, Inc.